http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-591108-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
filingDate 2009-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_340747f9310b7b147c56544e2f30ed6b
publicationDate 2012-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-591108-A
titleOfInvention Dabigatran for percutaneous interventional cardiac catheterisation
abstract Disclosed is the use of dabigatran etexilate, for the manufacture of a medicament for secondary medication in percutaneous, interventional cardiac catheterisation conducted in conjunction with implanting of a stent.
priorityDate 2008-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135565674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541365

Total number of triples: 21.